Editorial
Published on 04 Jan 2024
Editorial: The role of E2F transcription factors in cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1355610
- 2,464 views
- 4 citations
Type at least 3 characters
3,128 articles
articles
Review
Published on 04 Jan 2024
Potential markers of cancer stem-like cells in ESCC: a review of the current knowledge
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1324819
- 4,346 views
- 7 citations
Opinion
Published on 21 Dec 2023
Opinion: the nature of primary and secondary synovial chondromatosis: importance of pathological findings
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1281890
- 1,553 views
- 2 citations
Review
Published on 20 Dec 2023
Prostate transmembrane androgen inducible protein 1 (PMEPA1): regulation and clinical implications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1298660
- 4,755 views
- 5 citations
Review
Published on 19 Dec 2023
Multiomics insights on the onset, progression, and metastatic evolution of breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1292046
- 8,784 views
- 6 citations
Review
Published on 19 Dec 2023
Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1247399
- 5,696 views
- 3 citations
Review
Published on 18 Dec 2023
Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1273516
- 9,783 views
- 19 citations
Original Research
Published on 13 Dec 2023
Human polyomaviruses JCPyV and MCPyV in urothelial cell carcinoma: a single institution experience
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1251244
- 3,140 views
- 1 citation
Review
Published on 11 Dec 2023
The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1278004
- 5,448 views
- 5 citations
Review
Published on 11 Dec 2023
Vascular co-option in resistance to anti-angiogenic therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1323350
- 3,937 views
- 15 citations
Original Research
Published on 08 Dec 2023
GIPC1 regulates MACC1-driven metastasis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1280977
- 3,860 views
- 2 citations
Review
Published on 08 Dec 2023
Epigenetic targeting of autophagy for cancer: DNA and RNA methylation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1290330
- 4,688 views
- 3 citations
Original Research
Published on 08 Dec 2023
Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1307838
- 5,834 views
- 4 citations
Retraction
Published on 07 Dec 2023
Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1343833
- 2,976 views
Review
Published on 07 Dec 2023
Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1250766
- 5,450 views
- 4 citations
Review
Published on 05 Dec 2023
CAR-T treatment for cancer: prospects and challenges
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1288383
- 15,239 views
- 19 citations
Case Report
Published on 05 Dec 2023
A rare adverse effects of COVID-19 vaccine in a patient with a latent tumor: A case report and literature review
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1269735
- 10,873 views
- 2 citations
Original Research
Published on 04 Dec 2023
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1271807
- 3,753 views
- 5 citations
Original Research
Published on 30 Nov 2023
Serum exosomal circCCDC66 as a potential diagnostic and prognostic biomarker for pituitary adenomas
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1268778
- 2,024 views
- 5 citations
Review
Published on 30 Nov 2023
The development of cancers research based on mitochondrial heat shock protein 90
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1296456
- 4,995 views
- 10 citations
Editorial
Published on 29 Nov 2023
Editorial: Molecular and cellular mechanisms for cancer therapy resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1340318
- 1,752 views
- 1 citation
Editorial
Published on 23 Nov 2023
Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1337315
- 1,686 views
Editorial
Published on 23 Nov 2023
Editorial: Hallmark of cancer: sustained proliferative signalling
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1328827
- 4,568 views
- 6 citations
Original Research
Published on 23 Nov 2023
Structural characterization of human de novo protein NCYM and its complex with a newly identified DNA aptamer using atomic force microscopy and small-angle X-ray scattering
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1213678
- 5,535 views
- 7 citations